Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Aging

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

The Effect of Aging on Tissues

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inconvenient Truths About Human Longevity.

The journals of gerontology. Series A, Biological sciences and medical sciences·2019

Same author

Primary Prevention with a Capital <i>P</i>.

Perspectives in biology and medicine·2018

Same author

Cardiovascular effects of fission neutron or <sup>60</sup>Co γ exposure in the B6CF<sub>1</sub> mouse.

International journal of radiation biology·2017

Same author

Genetic variation in the raptor gene is associated with overweight but not hypertension in American men of Japanese ancestry.

American journal of hypertension·2014

Same author

Impact of climate change on elder health.

The journals of gerontology. Series A, Biological sciences and medical sciences·2013

Same author

How long must humans live?

The journals of gerontology. Series A, Biological sciences and medical sciences·2013

Search research articles

Related Experiment Video

Updated: Apr 9, 2026

Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging

Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging

Published on: January 30, 2026

Can Any Biomarker Predict the Temporal Behavior of Aging?

Bruce A Carnes¹

¹Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Okla., USA.

|June 20, 2015

Summary

This study questions the validity of aging biomarkers. It argues that aging remains an unsolved problem, and current disease-focused databases may lack variables crucial for understanding aging mortality dynamics.

Area of Science:

Gerontology
Biomarker Research
Aging Biology

Background:

Numerous studies focus on physiological biomarkers linked to aging.
Aging is presented as a persistent, unresolved challenge in biological sciences.
The development of reliable aging biomarkers is an ongoing area of research.

Purpose of the Study:

To critically evaluate the possibility of creating biomarkers for aging mortality dynamics.
To examine the foundational requirements for developing valid biological phenomenon biomarkers.
To question the suitability of existing disease-centric datasets for aging research.

Main Methods:

Conceptual analysis of biomarker development principles.
Literature review on aging research and biomarker studies.

More Related Videos

Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine

Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine

Published on: January 26, 2024

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Related Experiment Videos

Last Updated: Apr 9, 2026

Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging

Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging

Published on: January 30, 2026

Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine

Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine

Published on: January 26, 2024

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Argumentative critique of current gerontological research paradigms.

Main Results:

Aging remains a fundamental unresolved problem in gerontology.
Biomarkers require an evidence-based conceptual framework and relevant variables.
Existing disease-focused databases may be inadequate for studying aging mortality.

Conclusions:

The creation of accurate biomarkers for aging mortality dynamics is questionable.
A robust conceptual framework is essential for biomarker development in aging.
Further research is needed to identify appropriate variables for aging biomarker studies.